Summary Microsatellite instability has recently been reported in sporadic and familial colorectal tumours and can be due to defects in DNA mismatch repair genes. Such instability has subsequently been detected in several other types of sporadic tumours. We studied 29 specimens of bone tumours with different histopathological diagnoses and found no evidence of microsatellite instability. Our results suggest that mismatch repair defects are unlikely to play a significant part in the tumorigenesis of bone neoplasms. Loss of heterozygosity with at least one marker was detected in 11, i.e. in 38% of the tumour samples, most frequently with markers D2S136 at 2p (eight of 28 informative specimens, 29%) and Dl lS904 at llp (four of 21 informative specimens, 19%).
Microsatellite instability (MI) is a recently discovered landmark of a mutator or a replication error (RER) tumour phenotype, which was first described in sporadic (Ionov et al., 1993; Thibodeau et al., 1993) and hereditary (Aaltonen et al., 1993) colorectal tumours. The identification of the RER phenomenon gave decisive clues to the pathogenesis of hereditary non-polyposis colorectal cancer (HNPCC). The cancer predisposition in HNPCC has been shown to arise from germline mutations in DNA mismatch repair genes, most often affecting MLHI or MSH2 (Bronner et al., 1994; Leach et al., 1993; Nicolaides et al., 1994; Papadopoulos et al., 1994) . The (Parsons et al., 1993) and is believed to promote tumorigenesis.
Microsatellite instability has subsequently been detected in various tumours (for reviews, see Dams et al., 1995; Eshleman and Markowitz, 1995; Loeb, 1994) , including sporadic tumours of the endometrium, oesophagus, stomach, pancreas, ovary, kidney, urinary bladder, lung, brain, breast and prostate. MI has also been detected in skin cancer (Quinn et al., 1995) and squamous cell carcinoma of head and neck (Mao et al., 1994) . Data about MI in haematological malignancies are still conflicting (Robledo et al., 1995; Silly et al., 1994; Wada et al., 1994) . Whether the molecular genetic background in the above-mentioned RER+ tumour types is similar to HNPCC is yet unclear. It is likely that neoplasms with few microsatellite alterations represent still unclarified mechanisms of genetic instability different from the one seen in HNPCC and some sporadic colorectal tumours (Lieu et al., 1995) . As MI has been detected with a very low frequency and with only one marker in some tumour types, it is possible that a subset of these findings reflects only the general instability of the tumour genome and is merely a by-product of tumour progression.
As the spectrum of tumours with microsatellite instability has been shown to be wide, we hypothesised that such instability might play a role in the tumorigenesis of bone neoplasms. So far mesenchymal tumours have been screened for RER in only one study, in which two of 18 soft-tissue sarcomas exhibited instability with one repeat (Wooster et al., 1994) . In a study of loss of heterozygosity (LOH) in chondrosarcomas with markers linked to multiple hereditary exostoses loci no evidence of MI was seen (Raskind et al., 1995) . In the present study we decided to screen different types of malignant bone tumours (e.g. osteosarcoma, chondrosarcoma, Ewing's sarcoma, fibrosarcoma and malignant fibrous histiocytoma) for the presence of RER.
Materials and methods
Twenty-nine tumour specimens representing primary bone tumours, tumour recurrences and metastases with different histopathological diagnoses (Table I) , with paired blood DNA samples, were analysed with five to 11 randomly chosen dinucleotide repeat markers (mean, 9.7 markers per tumour) representing different chromosomes. The markers were DIS216 (ip), D2S136 (2p), D5S404 (5q), D7S519 (7), D8S255 (8p), DlOS197 (lOp), DllS904 (lip), D13S175 (13q), D15S120 (15), D17S787 (17q) and D20S100 (20) (Gyapay et al., 1994) . PCR and electrophoresis were performed as previously described (Peltomiiki et al., 1993) . All results were rechecked by a researcher experienced with RER analysis (LAA).
Results
There was no evidence of microsatellite instability in the 282 paired typings of bone tumour samples, including samples of osteosarcoma, chondrosarcoma, Ewing's sarcoma, primitive neuroectodermal tumour (PNET), chondromyxoid fibroma, fibrosarcoma, malignant fibrous histiocytoma and leiomyosarcoma. Loss of heterozygosity was detected with at least one marker in 11 specimens, i.e. in 38% of the tumour samples studied (Table II, Figure 1) . LOH was most frequently detected with markers D2S136 at 2p (eight of 28 informative specimens, 29%) and Dl lS904 at lIp (four of 21 informative specimens, 19%).
Discussion
Previous allelotyping studies of bone tumours are few and have focused on osteosarcoma (Toguchida et al., 1988; Yamaguchi et al., 1992) . These studies have found frequent LOH in different chromosomes, most often at 13q and 17p, probably reflecting the inactivation of RBJ and p53. The low frequency of LOH at 13q in the present study is most probably due to the marker D13S175 being located proximally (13ql 1) from the RBI locus (13ql4). The detection of LOH at several different chromosome arms in different tumour samples with varying frequency in the present study is in agreement with previous studies. It is possible that allelic losses detected in this study represent random genetic alterations rather than events associated with tumour progression.
As none of the paired typings showed microsatellite instability, we interpret this to suggest that MI is unlikely to be involved as a major component in the development of bone tumours. The study by Raskind et al. (1995) reported no MI in chondrosarcomas with markers located at 8q, the pericentromeric region of chromosome 11, and l9p. The results of the present study are in agreement with this study as none of the chondrosarcomas of the present study showed MI. Also other histopathological entities of bone tumours were included in the present study (e.g. osteosarcoma, Table  I ) and none showed MI. However, as a small proportion of soft-tissue sarcomas exhibited a low degree of MI in a previous study (Wooster et al., 1994) , it is still possible that microsatellite instability could be detected in a distinct subgroup of bone tumours, at least with a low degree. Furthermore, preliminary results of mice deficient for PMS2 or MSH2 have shown that these animals may be susceptible to developing sarcomas (Baker et al., 1995; de Wind et al., 1995) . Further studies will clarify whether MI and defects in mismatch repair or other mechanisms involved in the stability of DNA might contribute to the tumorigenesis of a bone tumour subgroup, or of mesenchymal tumours in general.
Note added in proof The tumours have been further studied for instability of the polyA repeat within the gene encoding TGFfl-RII (Papadopoulos et al. (1995) . Science, 268, 1915 Science, 268, -1917 , but no instability was detected.
